Privia Health Group, Inc. (NASDAQ:PRVA) CFO Sells $125,999.40 in Stock

Privia Health Group, Inc. (NASDAQ:PRVAGet Free Report) CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company’s stock, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $21.97 on Friday. The firm has a market capitalization of $2.65 billion, a PE ratio of 219.72, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $26.04. The stock’s 50-day simple moving average is $23.78 and its 200-day simple moving average is $21.31.

Institutional Trading of Privia Health Group

A number of large investors have recently bought and sold shares of the business. Quadrant Capital Group LLC lifted its stake in shares of Privia Health Group by 11.8% in the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the period. Park Avenue Securities LLC lifted its position in shares of Privia Health Group by 3.8% during the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after acquiring an additional 532 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of Privia Health Group by 8.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock valued at $140,000 after acquiring an additional 533 shares during the period. First Horizon Advisors Inc. boosted its stake in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares in the last quarter. Finally, Summit Investment Advisors Inc. grew its holdings in shares of Privia Health Group by 6.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock worth $209,000 after acquiring an additional 678 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on PRVA. Stephens reaffirmed an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research note on Friday, March 21st. Finally, Piper Sandler increased their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Privia Health Group has an average rating of “Buy” and an average target price of $26.67.

View Our Latest Research Report on PRVA

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Further Reading

Insider Buying and Selling by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.